Phio Pharmaceuticals Corp. (PHIO) Misses Q2 EPS by 6c

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q2 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.

You May Also Be Interested In

• Musalem: strong growth and investment influencing bond market - CNBC
• Leggett & Platt shareholders approve merger with Somnigroup
• Nvidia plans China chip shipments with export-compliant AI processor - The Information